Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis

BACKGROUND: Bladder cancer (BCa) is one of the important tumors that have been proven to be treatable with immunotherapy. This study aims to identify and validate a molecular prognostic index of BCa based on immunogenomic landscape analysis. METHODS: The cancer genome atlas (TCGA) database and immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ning, Ke, Zhi-Bin, Lin, Xiao-Dan, Chen, Ye-Hui, Wu, Yu-Peng, Chen, Yu, Dong, Ru-Nan, Chen, Shao-Hao, Li, Xiao-Dong, Wei, Yong, Zheng, Qing-Shui, Lin, Yun-Zhi, Xue, Xue-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353795/
https://www.ncbi.nlm.nih.gov/pubmed/32675942
http://dx.doi.org/10.1186/s12935-020-01343-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353795/
https://www.ncbi.nlm.nih.gov/pubmed/32675942
http://dx.doi.org/10.1186/s12935-020-01343-3

Ejemplares similares